Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

1. Exosomal noncoding RNA (ncRNA) in breast cancer pathogenesis and therapy; two sides of the same coin

   Fatma M. Ibrahim, Raed Obaid Saleh, Herlina Uinarni +7

   Шарҳ мақолаCircular RNAs in diseasesExperimental Cell Research20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000096

2. From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis

   Jitendra Gupta, Bahaa Ibrahim Saeed, Ashok Kumar Bishoyi +7

   Шарҳ мақолаRNA modifications and cancerMedical Oncology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000027